These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23973558)

  • 1. Reply to vorinostat induced bone loss in mice.
    McGee-Lawrence ME; Westendorf JJ
    Bone; 2013 Dec; 57(2):531-2. PubMed ID: 23973558
    [No Abstract]   [Full Text] [Related]  

  • 2. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.
    McGee-Lawrence ME; McCleary-Wheeler AL; Secreto FJ; Razidlo DF; Zhang M; Stensgard BA; Li X; Stein GS; Lian JB; Westendorf JJ
    Bone; 2011 May; 48(5):1117-26. PubMed ID: 21255693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vorinostat-induced bone loss might be related to drug toxicity.
    Xu S; De Veirman K; Vanderkerken K; Van Riet I
    Bone; 2013 Dec; 57(2):384-5. PubMed ID: 23999199
    [No Abstract]   [Full Text] [Related]  

  • 4. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
    Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
    Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation.
    Lee JW; Asai M; Jeon SK; Iimura T; Yonezawa T; Cha BY; Woo JT; Yamaguchi A
    Mol Nutr Food Res; 2015 Mar; 59(3):386-400. PubMed ID: 25380345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade.
    Chen JR; Shankar K; Nagarajan S; Badger TM; Ronis MJ
    J Pharmacol Exp Ther; 2008 Jan; 324(1):50-9. PubMed ID: 17916759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucocorticoid-induced osteoporosis--epidemiology and pathogenesis].
    Suzuki Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():668-72. PubMed ID: 15035206
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
    Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency.
    Schiltz C; Marty C; de Vernejoul MC; Geoffroy V
    J Cell Biochem; 2008 Aug; 104(5):1803-17. PubMed ID: 18384129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Library Screen Identifies Abexinostat as Novel Regulator of Adipocytic and Osteoblastic Differentiation of Human Skeletal (Mesenchymal) Stem Cells.
    Ali D; Hamam R; Alfayez M; Kassem M; Aldahmash A; Alajez NM
    Stem Cells Transl Med; 2016 Aug; 5(8):1036-47. PubMed ID: 27194745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDF8 inhibits bone formation and promotes bone resorption in mice.
    Chen YS; Guo Q; Guo LJ; Liu T; Wu XP; Lin ZY; He HB; Jiang TJ
    Clin Exp Pharmacol Physiol; 2017 Apr; 44(4):500-508. PubMed ID: 28074479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminosuberoyl hydroxamic acids (ASHAs): a potent new class of HDAC inhibitors.
    Belvedere S; Witter DJ; Yan J; Secrist JP; Richon V; Miller TA
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3969-71. PubMed ID: 17507219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival.
    Ochi H; Hara Y; Tagawa M; Shinomiya K; Asou Y
    J Orthop Res; 2010 May; 28(5):657-63. PubMed ID: 19890995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
    Park CK; Kim HJ; Kwak HB; Lee TH; Bang MH; Kim CM; Lee Y; Chung DK; Baek NI; Kim J; Lee ZH; Kim HH
    Int Immunopharmacol; 2007 Dec; 7(12):1507-16. PubMed ID: 17920527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of tributyltin and 2,3,7,8-tetrachlorodibenzo-p-dioxin on differentiating osteoblasts and osteoclasts.
    Koskela A; Viluksela M; Keinänen M; Tuukkanen J; Korkalainen M
    Toxicol Appl Pharmacol; 2012 Sep; 263(2):210-7. PubMed ID: 22749964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib prevents ovariectomy-induced osteoporosis in mice by inhibiting osteoclast differentiation.
    Kim SH; Kim MO; Kim HJ; Neupane S; Kim HJ; Lee JH; Kim HH; Kim JY; Lee Y
    J Bone Miner Metab; 2018 Sep; 36(5):537-546. PubMed ID: 29027021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.